Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3949561000168118 | Epclusa (sofosbuvir 400 mg + velpatasvir 100 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3949571000168112 | Epclusa tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Epclusa tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Epclusa tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Epclusa tablet | Is a | Epclusa | true | Inferred relationship | Some | ||
| Epclusa tablet | Is a | sofosbuvir 400 mg + velpatasvir 100 mg tablet | true | Inferred relationship | Some | ||
| Epclusa tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Epclusa tablet | has unit of use | tablet | true | Inferred relationship | Some | 1038821653 | |
| Epclusa tablet | has intended active ingredient | sofosbuvir | true | Inferred relationship | Some | 520910218 | |
| Epclusa tablet | has Australian BoSS | sofosbuvir | true | Inferred relationship | Some | 520910218 | |
| Epclusa tablet | has Australian BoSS | velpatasvir | true | Inferred relationship | Some | 1038821652 | |
| Epclusa tablet | has intended active ingredient | velpatasvir | true | Inferred relationship | Some | 1038821652 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Epclusa tablet, 28, bottle | has TPUU | True | Epclusa tablet | Inferred relationship | Some | 1 |
| Epclusa tablet, 28 | has TPUU | True | Epclusa tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR